ON THE CLINICAL SIGNIFICANCE OF FACTORS PREDICING THE DEVELOPMENT OF PATHOLOGY OF THE ESOPHAGUS AND STOMACH IN BRONCHIAL ASTHMA

Authors

  • Khairulleva S. S.

    Tashkent State Medical University, Uzbekistan

    Author

Keywords:
Bronchial asthma, glucocorticosteroids, esophageal and gastric damage, prognostic predictors
Abstract

The article presents the results of studying the frequency and nature of esophageal and gastric lesions in bronchial asthma patients and assessing causal risk factors for their development and criteria for predicting their formation. The regimens for administering glucocorticosteroid therapy (GCS) for bronchial asthma and the daily doses of GCS were closely related to the clinical manifestations of the lesions. Smoking, alcohol consumption, consumption of very cold drinks, incorrect use of inhalers, body mass index over 30, use of systemic glucocorticosteroids at doses exceeding 10 mg/day and their prolonged use for more than 5 years, as well as the use of inhaled glucocorticosteroids at doses exceeding 1000 mcg/day and their prolonged use for more than 5 years are important prognostic factors. These factors significantly increase the likelihood of developing gastric and esophageal diseases.

References

[1]Васильев. Ю.В. Бронхиальная астма, сочетающаяся с гастроэзофагеальной рефлюксной болезнью. Лечащий врач, № №4., 2011.

[2]Горбань В.В.; Ковригина И.В.; Горбань Е.В. Синтропия бронхиальной астмы и гастроэзофагеальной рефлюксной болезни: патогенетические особенности и возможности малоинвазивной диагностики на амбулаторном этапе. Южно-Российский журнал терапевтической практики. №4, С.25-35, 2023.

[3]

Убайдуллаев А.М., Ливерко И.В., Абдуллаев В.А. Кортикозависимость и кортикорезистентность у больных бронхиальной астмой. Вестник Ассоциации пульмонологов Центральной Азии. Вып.14(№3-4). С.162-163, 2010.

[4]

Хайруллаева С.С. Клинико-патогенетическая характеристика пораже-ний гастродуоденальной зоны при гормонозависимой бронхиальной астме и пути их коррекции. Автореферат диссер. РhD по медицинским наукам, Ташкент. 2018.

[5]

Abubakr A. B.; Faisal U,; Vinny S.; James D. C.; Adil Sh. Impact of GERD on Common Pulmonary Dis. Northeast Florida Medicine. Vol.62. №1, pp. Р.31-34, 2011.

[6]

Global Initiative for Astma, all rights reserved. Use is by express license from the owner. 2014.

[7]

G. S. Gaude, «Pulmonary manifestations of gastroesophageal reflux disease. Ann. Thorac. Med. Vol. 4. № 3. P. 115–123, 2009.

[8]

Cazzola M.; Rogliani P.; Ora J.; Calzetta L.; Matera MG;, «Asthma and comorbidities: recent advances,» Pol Arch Intern Med, p. 132(4):16250, 2022.

[9] McCalhster J.W.; Parsons J.; Mastronarde J.G. The relationship between gastroesophageal reflux and asthma: an update. Ther. Adv. Respir. Dis., pp. Oct. &- P. 224-227, 2010.

[10] Камилова, У. К., Икрамова, Ф. А., Аликулов, И. Т., & Абдуллаева, Ч. А. (2021). Оценка показателей качества жизни у больных хронической сердечной недостаточностью с дисфункцией почек. In ХVI Национальный конгресс терапевтов с международным участием (pp. 29-29).

[11] Yadlapati R.; Pandolfino J.E. Personalized approach in the work-upand management of gastroesophageal reflux disease. Gastrointest.Endosc. Clin. N. Am. , p. 30(2): 227–38, 2020.

Downloads
Published
2026-04-13
Issue
Vol. 2 No. 4 (2026)
Section
Articles
License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

ON THE CLINICAL SIGNIFICANCE OF FACTORS PREDICING THE DEVELOPMENT OF PATHOLOGY OF THE ESOPHAGUS AND STOMACH IN BRONCHIAL ASTHMA. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(4), 142-148. https://eurekaoa.com/index.php/5/article/view/784